These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Disopyramide binding to serum protein in man and animals. Lima JJ; Haughey DB Drug Metab Dispos; 1981; 9(6):582-3. PubMed ID: 6120822 [No Abstract] [Full Text] [Related]
7. Pharmacokinetics of disopyramide administered by intramuscular, intravenous and oral routes to normal volunteers [proceedings]. Ashford JJ; Carmichael D; Kidner PH Br J Pharmacol; 1979 Jul; 66(3):442P-443P. PubMed ID: 526732 [No Abstract] [Full Text] [Related]
8. Disopyramide kinetics in renal impairment: determinants of interindividual variability. Burk M; Peters U Clin Pharmacol Ther; 1983 Sep; 34(3):331-40. PubMed ID: 6883909 [TBL] [Abstract][Full Text] [Related]
9. Disposition kinetics of disopyramide in patients with renal insufficiency. Shen DD; Cunningham JL; Shudo I; Azarnoff DL Biopharm Drug Dispos; 1980; 1(3):133-40. PubMed ID: 7448340 [TBL] [Abstract][Full Text] [Related]
10. Influence of concentration-dependent protein binding on serum concentrations and urinary excretion of disopyramide and its metabolite following oral administration. Haughey DB; Lima JJ Biopharm Drug Dispos; 1983; 4(2):103-12. PubMed ID: 6882879 [TBL] [Abstract][Full Text] [Related]
12. The influence of protein binding on disopyramide clearance. Bryson SM; Lawrence JR; Steele WH; Campbell BC; Elliott HL; Sumner DJ Eur J Clin Pharmacol; 1982; 23(5):453-6. PubMed ID: 7151851 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic study of disopyramide in normal man]. Mallein R; Rondelet J; Boucherat M; Ksavrelof M; Pignat M Therapie; 1978; 33(4):463-73. PubMed ID: 734626 [No Abstract] [Full Text] [Related]
14. Comparative bioavailability of disopyramide after multiple dosing with standard capsules and controlled-release tablets. Forssell G; Graffner C; Nordlander R; Nyquist O Eur J Clin Pharmacol; 1980; 17(3):209-13. PubMed ID: 7363933 [TBL] [Abstract][Full Text] [Related]
15. Disopyramide pharmacokinetics during recovery from myocardial infarction. Bryson SM; Cairns CJ; Whiting B Br J Clin Pharmacol; 1982 Mar; 13(3):417-21. PubMed ID: 7059444 [TBL] [Abstract][Full Text] [Related]
16. [Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide]. Witkowska M Kardiol Pol; 1981; 24(7):505-17. PubMed ID: 7024612 [No Abstract] [Full Text] [Related]
17. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability. Bryson SM; Whiting B; Lawrence JR Br J Clin Pharmacol; 1978 Nov; 6(5):409-19. PubMed ID: 728284 [TBL] [Abstract][Full Text] [Related]